The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Le, Y.
Right arrow Articles by Wang, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Le, Y.
Right arrow Articles by Wang, J. M.
The Journal of Immunology, 1999, 163: 6777-6784.
Copyright © 1999 by The American Association of Immunologists

Utilization of Two Seven-Transmembrane, G Protein-Coupled Receptors, Formyl Peptide Receptor-Like 1 and Formyl Peptide Receptor, by the Synthetic Hexapeptide WKYMVm for Human Phagocyte Activation1

Yingying Le*, Wanghua Gong{dagger}, Baoqun Li{dagger}, Nancy M. Dunlop*, Weiping Shen*, Shao Bo Su*, Richard D. Ye{ddagger} and Ji Ming Wang2,*

* Laboratory of Molecular Immunoregulation, Division of Basic Sciences, National Cancer Institute-Frederick Cancer Research and Development Center and {dagger} Intramural Research Support Program, Science Applications International Corp.-Frederick, Frederick, MD 21702; and {ddagger} Department of Pharmacology, University of Illinois, Chicago, IL 60612

Trp-Lys-Tyr-Val-D-Met (WKYMVm) is a synthetic leukocyte-activating peptide postulated to use seven-transmembrane, G protein-coupled receptor(s). In the study to characterize the receptor(s) for WKYMVm, we found that this peptide induced marked chemotaxis and calcium flux in human phagocytes. The signaling induced by WKYMVm in phagocytes was attenuated by high concentrations of the bacterial chemotactic peptide fMLP, suggesting that WKYMVm might use receptor(s) for fMLP. This hypothesis was tested by using cells over expressing genes encoding two seven-transmembrane receptors, formyl peptide receptor (FPR) and formyl peptide receptor-like 1 (FPRL1), which are with high and low affinity for fMLP, respectively. Both FPR- and FPRL1-expressing cells mobilized calcium in response to picomolar concentrations of WKYMVm. While FPRL1-expressing cells migrated to picomolar concentrations of WKYMVm, nanomolar concentrations of the peptide were required to induce migration of FPR-expressing cells. In contrast, fMLP elicited both calcium flux and chemotaxis only in FPR-expressing cells with an efficacy comparable with WKYMVm. Thus, WKYMVm uses both FPR and FPRL1 to stimulate phagocytes with a markedly higher efficacy for FPRL1. Our study suggests that FPR and FPRL1 in phagocytes react to a broad spectrum of agonists and WKYMVm as a remarkably potent agonist provides a valuable tool for studying leukocyte signaling via these receptors.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
E. L. Southgate, R. L. He, J.-L. Gao, P. M. Murphy, M. Nanamori, and R. D. Ye
Identification of Formyl Peptides from Listeria monocytogenes and Staphylococcus aureus as Potent Chemoattractants for Mouse Neutrophils
J. Immunol., July 15, 2008; 181(2): 1429 - 1437.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
I. Berkestedt, A. Nelson, and M. Bodelsson
Endogenous antimicrobial peptide LL-37 induces human vasodilatation
Br. J. Anaesth., June 1, 2008; 100(6): 803 - 809.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Yu, N. Mookherjee, K. Wee, D. M. E. Bowdish, J. Pistolic, Y. Li, L. Rehaume, and R. E. W. Hancock
Host Defense Peptide LL-37, in Synergy with Inflammatory Mediator IL-1beta, Augments Immune Responses by Multiple Pathways
J. Immunol., December 1, 2007; 179(11): 7684 - 7691.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
C. Lin, W. Wei, J. Zhang, S. Liu, Y. Liu, and D. Zheng
Formyl peptide receptor-like 1 mediated endogenous TRAIL gene expression with tumoricidal activity
Mol. Cancer Ther., October 1, 2007; 6(10): 2618 - 2625.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
C. Zhou, S. Zhang, M. Nanamori, Y. Zhang, Q. Liu, N. Li, M. Sun, J. Tian, P. P. Ye, N. Cheng, et al.
Pharmacological Characterization of a Novel Nonpeptide Antagonist for Formyl Peptide Receptor-Like 1
Mol. Pharmacol., October 1, 2007; 72(4): 976 - 983.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Z. Miao, B. A. Premack, Z. Wei, Y. Wang, C. Gerard, H. Showell, M. Howard, T. J. Schall, and R. Berahovich
Proinflammatory Proteases Liberate a Discrete High-Affinity Functional FPRL1 (CCR12) Ligand from CCL23
J. Immunol., June 1, 2007; 178(11): 7395 - 7404.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Prat, J. Bestebroer, C. J. C. de Haas, J. A. G. van Strijp, and K. P. M. van Kessel
A New Staphylococcal Anti-Inflammatory Protein That Antagonizes the Formyl Peptide Receptor-Like 1
J. Immunol., December 1, 2006; 177(11): 8017 - 8026.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. Yan, M. Nanamori, M. Sun, C. Zhou, N. Cheng, N. Li, W. Zheng, L. Xiao, X. Xie, R. D. Ye, et al.
The Immunosuppressant Cyclosporin A Antagonizes Human Formyl Peptide Receptor through Inhibition of Cognate Ligand Binding
J. Immunol., November 15, 2006; 177(10): 7050 - 7058.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M.-S. Lee, S.-A. Yoo, C.-S. Cho, P.-G. Suh, W.-U. Kim, and S. H. Ryu
Serum Amyloid A Binding to Formyl Peptide Receptor-Like 1 Induces Synovial Hyperplasia and Angiogenesis
J. Immunol., October 15, 2006; 177(8): 5585 - 5594.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Kim, B. D. Lee, O. Kim, Y.-S. Bae, T. Lee, P.-G. Suh, and S. H. Ryu
Pituitary adenylate cyclase-activating polypeptide 27 is a functional ligand for formyl Peptide receptor-like 1.
J. Immunol., March 1, 2006; 176(5): 2969 - 2975.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
R. P. G. Hayhoe, A. M. Kamal, E. Solito, R. J. Flower, D. Cooper, and M. Perretti
Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement
Blood, March 1, 2006; 107(5): 2123 - 2130.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
M. L. Block, G. Li, L. Qin, X. Wu, Z. Pei, T. Wang, B. Wilson, J. Yang, and J. S. Hong
Potent regulation of microglia-derived oxidative stress and dopaminergic neuron survival: substance P vs. dynorphin
FASEB J, February 1, 2006; 20(2): 251 - 258.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
Q. Tian, J. Li, X. Xie, M. Sun, H. Sang, C. Zhou, T. An, L. Hu, R. D. Ye, and M.-W. Wang
Stereospecific Induction of Nuclear Factor-{kappa}B Activation by Isochamaejasmin
Mol. Pharmacol., December 1, 2005; 68(6): 1534 - 1542.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. K. Kang, H.-Y. Lee, M.-K. Kim, K. S. Park, Y. M. Park, J.-Y. Kwak, and Y.-S. Bae
The Synthetic Peptide Trp-Lys-Tyr-Met-Val-D-Met Inhibits Human Monocyte-Derived Dendritic Cell Maturation via Formyl Peptide Receptor and Formyl Peptide Receptor-Like 2
J. Immunol., July 15, 2005; 175(2): 685 - 692.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
Y. Zhou, X. Bian, Y. Le, W. Gong, J. Hu, X. Zhang, L. Wang, P. Iribarren, R. Salcedo, O. M. Z. Howard, et al.
Formylpeptide Receptor FPR and the Rapid Growth of Malignant Human Gliomas
J Natl Cancer Inst, June 1, 2005; 97(11): 823 - 835.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Kurosaka, Q. Chen, F. Yarovinsky, J. J. Oppenheim, and D. Yang
Mouse Cathelin-Related Antimicrobial Peptide Chemoattracts Leukocytes Using Formyl Peptide Receptor-Like 1/Mouse Formyl Peptide Receptor-Like 2 as the Receptor and Acts as an Immune Adjuvant
J. Immunol., May 15, 2005; 174(10): 6257 - 6265.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
I. Migeotte, E. Riboldi, J.-D. Franssen, F. Gregoire, C. Loison, V. Wittamer, M. Detheux, P. Robberecht, S. Costagliola, G. Vassart, et al.
Identification and characterization of an endogenous chemotactic ligand specific for FPRL2
J. Exp. Med., January 3, 2005; 201(1): 83 - 93.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. de Paulis, N. Montuori, N. Prevete, I. Fiorentino, F. W. Rossi, V. Visconte, G. Rossi, G. Marone, and P. Ragno
Urokinase Induces Basophil Chemotaxis through a Urokinase Receptor Epitope That Is an Endogenous Ligand for Formyl Peptide Receptor-Like 1 and -Like 2
J. Immunol., November 1, 2004; 173(9): 5739 - 5748.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
M. Nanamori, X. Cheng, J. Mei, H. Sang, Y. Xuan, C. Zhou, M.-W. Wang, and R. D. Ye
A Novel Nonpeptide Ligand for Formyl Peptide Receptor-Like 1
Mol. Pharmacol., November 1, 2004; 66(5): 1213 - 1222.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
Y. Le, P. Iribarren, Y. Zhou, W. Gong, J. Hu, X. Zhang, and J. M. Wang
Silencing the Formylpeptide Receptor FPR by Short-Interfering RNA
Mol. Pharmacol., October 1, 2004; 66(4): 1022 - 1028.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Q. Chen, D. Wade, K. Kurosaka, Z. Y. Wang, J. J. Oppenheim, and D. Yang
Temporin A and Related Frog Antimicrobial Peptides Use Formyl Peptide Receptor-Like 1 as a Receptor to Chemoattract Phagocytes
J. Immunol., August 15, 2004; 173(4): 2652 - 2659.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y.-S. Bae, H. Y. Lee, E. J. Jo, J. I. Kim, H.-K. Kang, R. D. Ye, J.-Y. Kwak, and S. H. Ryu
Identification of Peptides That Antagonize Formyl Peptide Receptor-Like 1-Mediated Signaling
J. Immunol., July 1, 2004; 173(1): 607 - 614.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Ernst, C. Lange, A. Wilbers, V. Goebeler, V. Gerke, and U. Rescher
An Annexin 1 N-Terminal Peptide Activates Leukocytes by Triggering Different Members of the Formyl Peptide Receptor Family
J. Immunol., June 15, 2004; 172(12): 7669 - 7676.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. de Paulis, N. Prevete, I. Fiorentino, A. F. Walls, M. Curto, A. Petraroli, V. Castaldo, P. Ceppa, R. Fiocca, and G. Marone
Basophils Infiltrate Human Gastric Mucosa at Sites of Helicobacter pylori Infection, and Exhibit Chemotaxis in Response to H. pylori-derived Peptide Hp(2-20)
J. Immunol., June 15, 2004; 172(12): 7734 - 7743.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
G. Ying, P. Iribarren, Y. Zhou, W. Gong, N. Zhang, Z.-X. Yu, Y. Le, Y. Cui, and J. M. Wang
Humanin, a Newly Identified Neuroprotective Factor, Uses the G Protein-Coupled Formylpeptide Receptor-Like-1 as a Functional Receptor
J. Immunol., June 1, 2004; 172(11): 7078 - 7085.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Elssner, M. Duncan, M. Gavrilin, and M. D. Wewers
A Novel P2X7 Receptor Activator, the Human Cathelicidin-Derived Peptide LL37, Induces IL-1{beta} Processing and Release
J. Immunol., April 15, 2004; 172(8): 4987 - 4994.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Partida-Sanchez, P. Iribarren, M. E. Moreno-Garcia, J.-L. Gao, P. M. Murphy, N. Oppenheimer, J. M. Wang, and F. E. Lund
Chemotaxis and Calcium Responses of Phagocytes to Formyl Peptide Receptor Ligands Is Differentially Regulated by Cyclic ADP Ribose
J. Immunol., February 1, 2004; 172(3): 1896 - 1906.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
Y.-S. Bae, J. Y. Song, Y. Kim, R. He, R. D. Ye, J.-Y. Kwak, P.-G. Suh, and S. H. Ryu
Differential Activation of Formyl Peptide Receptor Signaling by Peptide Ligands
Mol. Pharmacol., October 1, 2003; 64(4): 841 - 847.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
Y.-S. Bae, J. C. Park, R. He, R. D. Ye, J.-Y. Kwak, P.-G. Suh, and S. Ho Ryu
Differential Signaling of Formyl Peptide Receptor-Like 1 by Trp-Lys-Tyr-Met-Val-Met-CONH2 or Lipoxin A4 in Human Neutrophils
Mol. Pharmacol., September 1, 2003; 64(3): 721 - 730.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. de Paulis, G. Florio, N. Prevete, M. Triggiani, I. Fiorentino, A. Genovese, and G. Marone
HIV-1 Envelope gp41 Peptides Promote Migration of Human Fc{epsilon}RI+ Cells and Inhibit IL-13 Synthesis Through Interaction with Formyl Peptide Receptors
J. Immunol., October 15, 2002; 169(8): 4559 - 4567.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
Y. Cui, Y. Le, H. Yazawa, W. Gong, and J. M. Wang
Potential role of the formyl peptide receptor-like 1 (FPRL1) in inflammatory aspects of Alzheimer's disease
J. Leukoc. Biol., October 1, 2002; 72(4): 628 - 635.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
D. Yang, Q. Chen, B. Gertz, R. He, M. Phulsuksombati, R. D. Ye, and J. J. Oppenheim
Human dendritic cells express functional formyl peptide receptor-like-2 (FPRL2) throughout maturation
J. Leukoc. Biol., September 1, 2002; 72(3): 598 - 607.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
M. Gouwy, S. Struyf, F. Mahieu, W. Put, P. Proost, and J. Van Damme
The Unique Property of the CC Chemokine Regakine-1 to Synergize with Other Plasma-Derived Inflammatory Mediators in Neutrophil Chemotaxis Does Not Reside in Its NH2-Terminal Structure
Mol. Pharmacol., July 1, 2002; 62(1): 173 - 180.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
Y.-S. Bae, Y. Kim, J. C. Park, P.-G. Suh, and S. H. Ryu
The synthetic chemoattractant peptide, Trp-Lys-Tyr-Met-Val-D-Met, enhances monocyte survival via PKC-dependent Akt activation
J. Leukoc. Biol., February 1, 2002; 71(2): 329 - 338.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y.-H. Cui, Y. Le, W. Gong, P. Proost, J. Van Damme, W. J. Murphy, and J. M. Wang
Bacterial Lipopolysaccharide Selectively Up-Regulates the Function of the Chemotactic Peptide Receptor Formyl Peptide Receptor 2 in Murine Microglial Cells
J. Immunol., January 1, 2002; 168(1): 434 - 442.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
H. YAZAWA, Z.-X. YU, TAKEDA, Y. LE, W. GONG, V. J. FERRANS, J. J. OPPENHEIM, C. C. H. LI, and J. M. WANG
{beta} Amyloid peptide (A{beta}42) is internalized via the G-protein-coupled receptor FPRL1 and forms fibrillar aggregates in macrophages
FASEB J, November 1, 2001; 15(13): 2454 - 2462.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
J. Y. Hu, Y. Le, W. Gong, N. M. Dunlop, J. L. Gao, P. M. Murphy, and J. M. Wang
Synthetic peptide MMK-1 is a highly specific chemotactic agonist for leukocyte FPRL1
J. Leukoc. Biol., July 1, 2001; 70(1): 155 - 161.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. L. Jaye, H. A. Edens, L. Mazzucchelli, and C. A. Parkos
Novel G Protein-Coupled Responses in Leukocytes Elicited by a Chemotactic Bacteriophage Displaying a Cell Type-Selective Binding Peptide
J. Immunol., June 15, 2001; 166(12): 7250 - 7259.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Yang, H. Sang, A. Rahman, D. Wu, A. B. Malik, and R. D. Ye
G{{alpha}}16 Couples Chemoattractant Receptors to NF-{{kappa}}B Activation
J. Immunol., June 1, 2001; 166(11): 6885 - 6892.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
B.-Q. Li, M. A. Wetzel, J. A. Mikovits, E. E. Henderson, T. J. Rogers, W. Gong, Y. Le, F. W. Ruscetti, and J. M. Wang
The synthetic peptide WKYMVm attenuates the function of the chemokine receptors CCR5 and CXCR4 through activation of formyl peptide receptor-like 1
Blood, May 15, 2001; 97(10): 2941 - 2947.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
Y.-S. Bae, H. Bae, Y. Kim, T. G. Lee, P.-G. Suh, and S. H. Ryu
Identification of novel chemoattractant peptides for human leukocytes
Blood, May 1, 2001; 97(9): 2854 - 2862.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. Yang, Q. Chen, Y. Le, J. M. Wang, and J. J. Oppenheim
Differential Regulation of Formyl Peptide Receptor-Like 1 Expression During the Differentiation of Monocytes to Dendritic Cells and Macrophages
J. Immunol., March 15, 2001; 166(6): 4092 - 4098.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. He, D. D. Browning, and R. D. Ye
Differential Roles of the NPXXY Motif in Formyl Peptide Receptor Signaling
J. Immunol., March 15, 2001; 166(6): 4099 - 4105.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Le, H. Yazawa, W. Gong, Z. Yu, V. J. Ferrans, P. M. Murphy, and J. M. Wang
Cutting Edge: The Neurotoxic Prion Peptide Fragment PrP106-126 Is a Chemotactic Agonist for the G Protein-Coupled Receptor Formyl Peptide Receptor-Like 1
J. Immunol., February 1, 2001; 166(3): 1448 - 1451.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. He, L. Tan, D. D. Browning, J. M. Wang, and R. D. Ye
The Synthetic Peptide Trp-Lys-Tyr-Met-Val-D-Met Is a Potent Chemotactic Agonist for Mouse Formyl Peptide Receptor
J. Immunol., October 15, 2000; 165(8): 4598 - 4605.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
De Yang, Q. Chen, A. P. Schmidt, G. M. Anderson, J. M. Wang, J. Wooters, J. J. Oppenheim, and O. Chertov
LL-37, the Neutrophil Granule- and Epithelial cell-derived Cathelicidin, Utilizes Formyl Peptide Receptor-like 1 (FPRL1) as a Receptor to Chemoattract Human Peripheral Blood Neutrophils, Monocytes, and T Cells
J. Exp. Med., October 2, 2000; 192(7): 1069 - 1074.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. S. Mills, H. M. Miettinen, D. Cummings, and A. J. Jesaitis
Characterization of the Binding Site on the Formyl Peptide Receptor Using Three Receptor Mutants and Analogs of Met-Leu-Phe and Met-Met-Trp-Leu-Leu
J. Biol. Chem., December 8, 2000; 275(50): 39012 - 39017.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Christophe, A. Karlsson, C. Dugave, M.-J. Rabiet, F. Boulay, and C. Dahlgren
The Synthetic Peptide Trp-Lys-Tyr-Met-Val-Met-NH2 Specifically Activates Neutrophils through FPRL1/Lipoxin A4 Receptors and Is an Agonist for the Orphan Monocyte-expressed Chemoattractant Receptor FPRL2
J. Biol. Chem., June 8, 2001; 276(24): 21585 - 21593.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.